Results 71 to 80 of about 490 (134)

Evaluation of alveolar ridge preservation in sockets with buccal dehiscence defects using two types of xenogeneic biomaterials: An in vivo experimental study

open access: yes, 2023
Objectives: Alveolar ridge preservation (ARP) has been extensively investigated in various preclinical and clinical studies, yielding favorable results.
Oh, Seunghan   +9 more
core   +1 more source

A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 12, Page 2026-2039, December 2025.
ABSTRACT Dulaglutide, a long‐acting glucagon‐like peptide‐1 (GLP‐1) receptor agonist, is approved for improving glycemic control and reducing cardiovascular risks in patients with type 2 diabetes mellitus (T2DM). This research investigates the effect of dulaglutide on gastric emptying and its impact on the pharmacokinetics (PK) of orally administered ...
Maria M. Posada   +9 more
wiley   +1 more source

Impact of gastric mixing and water intake on postprandial pharmacokinetics of orally disintegrating tablets: A PBBM-based study

open access: yesEuropean Journal of Pharmaceutics and Biopharmaceutics
Food intake substantially influences the oral absorption of many drugs, and the ability to quantitatively predict food effects in humans prior to clinical studies is critical for optimizing dosing regimens and formulation design. Although various in silico approaches have been proposed to predict food effects on oral solid dosage forms, their ...
Yoshinori Takahashi   +3 more
openaire   +2 more sources

An Open‐Source Framework for Virtual Bioequivalence Modeling and Clinical Trial Design

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 12, Page 1932-1948, December 2025.
ABSTRACT To establish bioequivalence (BE) of a generic test formulation with respect to a reference listed drug, it is necessary to demonstrate a comparable rate and extent to which active ingredients reach the site of action. To decrease unnecessary human testing and simulate scenarios involving specific populations or challenges with recruitment or ...
Abdullah Hamadeh   +13 more
wiley   +1 more source

Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations

open access: yesEuropean Journal of Pharmaceutical Sciences
Predicting the absorption of drugs from enabling formulations is still challenging due to the limited capabilities of standard physiologically based biopharmaceutics models (PBBMs) to capture complex absorption processes. Amongst others, it is often assumed that both, molecularly and apparently dissolved drug in the gastrointestinal lumen are prone to ...
Holzem, Florentin Lukas   +4 more
openaire   +2 more sources

Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b)

open access: yesPharmaceutics, 2020
In the present work, we explored if Coca-Cola® had a beneficial impact on the systemic outcome of the weakly basic drug loratadine (Wal-itin®, immediate-release formulation, 10 mg, generic drug product).
Bart Hens   +5 more
doaj   +1 more source

In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community

open access: yesThe Journal of Clinical Pharmacology, Volume 64, Issue 9, Page 1055-1067, September 2024.
Abstract Since the Open Source Initiative laid the foundation for the open source software environment in 1998, the popularity of free and open source software has been steadily increasing. Model‐informed drug discovery and development (MID3), a key component of pharmaceutical research and development, heavily makes use of computational models which ...
André Dallmann   +4 more
wiley   +1 more source

Tipifarnib physiologically‐based pharmacokinetic modeling to assess drug–drug interaction, organ impairment, and biopharmaceutics in healthy subjects and cancer patients

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 13, Issue 8, Page 1366-1379, August 2024.
Abstract A physiologically‐based pharmacokinetic (PBPK) model for tipifarnib, which included mechanistic absorption, was built and verified by integrating in vitro data and several clinical data in healthy subjects and cancer patients. The final PBPK model was able to recover the clinically observed single and multiple‐dose plasma concentrations of ...
Noriko Okudaira   +2 more
wiley   +1 more source

Physiologically Based Pharmacokinetic and Physiologically Based Biopharmaceutic models research in Latin America: A regional level bibliometric analysis, 2011-2023 [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences
The landscape of scientific research in Latin America (LA), particularly in the realms of the Physiologically Based Pharmacokinetic (PBPK) and Physiologically Based Biopharmaceutic models (PBPM), is a mosaic of varied contributions, collaborations, and ...
Marx Ribeiro   +5 more
doaj   +1 more source

Physiologically Based Biopharmaceutics Modeling (PBBM) to Evaluate the Biopredictive Power of Dissolution Methods for Rivaroxaban Tablets

open access: yes
The aim of this study was to use the physiologically based biopharmaceutics modeling (PBBM) strategy to evaluate the biopredictive power of different dissolution test conditions for immediate release tablets containing 20 mg of rivaroxaban. The model was developed and validated with literature data and used to predict plasma concentration-time curves ...
Eduardo Nabais de Carvalho Lauro   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy